One study described that up-regulation of hsa-miR-150 results in lung cancer proliferation by targeting p53, but in another study it was shown that hsa-miR-150 is down-regulated in NSCLC tissue [36, 37]. This evidence concerns the gene TP53 and lung carcinoma.